Alaunos Therapeutics, Inc. Operating Leases, Rent Expense
Alaunos Therapeutics, Inc. (TCRT) reported Operating Leases, Rent Expense of $0 for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-11-08
- Alaunos Therapeutics, Inc. operating leases, rent expense for the quarter ending 2021-09-30 was $0.00.
- Alaunos Therapeutics, Inc. operating leases, rent expense for the quarter ending 2021-06-30 was $5.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month |
|---|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-08 | $5.00K derived: sum of 2 quarters · filed 2021-11-08 | $5.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $5.00K 10-Q · filed 2021-08-13 | $5.00K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |